| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/28/2002 | EP1187845A4 Tumor suppressor molecules and methods of use |
| 08/28/2002 | EP1141270A4 Ethylene-response-factor1 (erf1) in plants |
| 08/28/2002 | EP1084133B1 Redox reversible bipyridyl osmium complex conjugates |
| 08/28/2002 | EP1062244B1 Improved methods for producing factor viii proteins |
| 08/28/2002 | EP0956155B1 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution |
| 08/28/2002 | EP0942978B1 Methods for producing the anaphase promoting complex |
| 08/28/2002 | EP0928201B1 Novel glycolipid complexes and their uses |
| 08/28/2002 | EP0863990B1 Use of anti-sense sequences to increase responsiveness to gene amplification |
| 08/28/2002 | EP0862454B1 Ctla-8 in combination with g-csf or with g-csf and il-6, and use of ctla-8 for treating infections |
| 08/28/2002 | EP0827591B1 Method for diagnosing chlamydia using an extracellular biological fluid |
| 08/28/2002 | EP0822828B1 Isolated 55 to 75 kda protein which binds to prion protein |
| 08/28/2002 | EP0821727A4 Method for producing a highly enriched population of osteoclast cells |
| 08/28/2002 | EP0632814B1 High molecular weight surface proteins of non-typeable haemophilus |
| 08/28/2002 | CN1366551A Escherichia coli strain secreting human granulocyte colony stimulating factor (G-CSF) |
| 08/28/2002 | CN1366062A Recombination carrier and treating composition used in insulin dependent diabetes gene curing |
| 08/28/2002 | CN1366052A Refractory ribosomal protein L-15 gene and its polypeptide coded by it and preparing process |
| 08/28/2002 | CN1366051A Modifying method and application of exilis protein gene |
| 08/28/2002 | CN1366049A Chinese bee venom AcHA gene, polypeptide coded by it and its preparing process |
| 08/28/2002 | CN1366047A Human DNA polymerase beta mutant gene and its corresponding protein |
| 08/28/2002 | CN1366046A Coding sequence, preparing process and application of human disease associated epidermal growth factor |
| 08/28/2002 | CN1366041A Broad spectrum infectious chicken blader disease virus vaccine |
| 08/28/2002 | CN1366040A Recombinant virus of human vascular endothelial growth inhibitor |
| 08/28/2002 | CN1365984A Parathyroid hormone analog and its preparing process by recombination |
| 08/28/2002 | CN1365983A Human alpha interferon derivative with superstrong antiviral activity |
| 08/28/2002 | CN1365982A Human interferon alpha-mutant |
| 08/28/2002 | CN1089803C Superoxide dismutase extracting process using chicken trunk |
| 08/28/2002 | CN1089617C Novel attinity ligands and their use |
| 08/28/2002 | CN1089607C Immunomodulatory complex for helicobacter bacteria |
| 08/28/2002 | CN1089606C Conjugate between modified superantigen and target-seeking compound and use of conjugate |
| 08/27/2002 | US6441276 Regeneration efficiency |
| 08/27/2002 | US6441273 Constitutive and inducible promoters from coffee plants |
| 08/27/2002 | US6441270 Scarecrow gene |
| 08/27/2002 | US6441157 Grass pollen |
| 08/27/2002 | US6441156 Calcium channel compositions and methods of use thereof |
| 08/27/2002 | US6441155 Isolated polynucleotide |
| 08/27/2002 | US6441151 Isolated nucleic acids |
| 08/27/2002 | US6441147 Batch commercial scale isolation of concentrated, active natural or recombinant proteins from intercellular material via vacuum and centrifugation; nondestructive to plants; pharmaceutical quality enzymes, cytokines and antibodies |
| 08/27/2002 | US6441145 Transgenically produced Antithrombin III |
| 08/27/2002 | US6441143 Identifying cancer patients with greatest probability of relapse; monoclonal antibody which binds to denatured epitope comprising a subset of amino acid residues 96-191; stomach, breast, lung, pancreatic, prostate or ovarian tumors |
| 08/27/2002 | US6441142 Detecting and quantifying allergens in foods; monoclonal antibody having antigen combining site with specificity for amino acid sequence arachis hypogaea ii; hybridoma cell lines which produce the antibodies |
| 08/27/2002 | US6441141 Synthetic peptides, antibodies against them and their use |
| 08/27/2002 | US6441138 Protein which induces interferon-γ production by immunocompetent cell |
| 08/27/2002 | US6441137 Tie-2 ligands; tie= ?tyrosine kinase with ig (immunoglobulins) and egf (epidermal growth factor) homology domains?; tumor neovascularization |
| 08/27/2002 | US6441136 Polypeptide of given amino acid sequence, modified by deleting amino acids near binding domains to prevent reaction with polyethylene glycol during conjugation to provide conjugated peptides with no decrease in activity |
| 08/27/2002 | US6441135 Bak binding protein, DNA encoding the protein, and methods of use thereof |
| 08/27/2002 | US6441134 Isolated Candida albicans oligopeptide transporter gene |
| 08/27/2002 | US6441133 Thyrotropin-releasing hormone receptor 2(TRHR-2) |
| 08/27/2002 | US6441132 Of given amino acid sequence (6-12 amino acids), including d-tryptophan residues; useful as anticonvulsant or neuroprotective agents |
| 08/27/2002 | US6441130 Form triple stranded structures with nucleic acids |
| 08/27/2002 | US6440980 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs |
| 08/27/2002 | US6440945 Enhancing blood perfusion ion by administering a dna encoding an angiogenic peptide; vascular endothelial growth factor (vegf) |
| 08/27/2002 | US6440939 Thrombin inhibitors |
| 08/27/2002 | US6440935 Such as cecropins and sarcotoxins |
| 08/27/2002 | US6440933 Compounds and method for the prevention and treatment of diabetic retinopathy |
| 08/27/2002 | US6440742 Recombinant AAV vector-based transduction system and use of same |
| 08/27/2002 | US6440741 Expression vector for consistent cellular expression of the tet on repressor in multiple cell types |
| 08/27/2002 | US6440736 Altering the properties of cells or of particles with membranes derived from cells by means of lipid-modified proteinaceous molecules |
| 08/27/2002 | US6440732 Checkpoint/repair genes involved with dna repair prior to replication; aging resistance; cancer therapy |
| 08/27/2002 | US6440730 Retroviral hybrid vectors pseudotyped with LCMV |
| 08/27/2002 | US6440727 Proteinase inhibitor, precursor thereof and genetic sequences encoding same |
| 08/27/2002 | US6440720 For use in recombinant protein production systems |
| 08/27/2002 | US6440719 Method and reagent for inhibiting herpes simplex virus replication |
| 08/27/2002 | US6440718 Recombination to produce hepatitis a virus; gene expression |
| 08/27/2002 | US6440702 For treatment of motor neuron diseases and muscle degenerative diseases; screening for therapeutic proteins by determining altered electrophoretic binding properties |
| 08/27/2002 | US6440701 Transferrin receptor genes of Moraxella |
| 08/27/2002 | US6440699 Prostate cancer susceptible CA7 CG04 gene |
| 08/27/2002 | US6440698 Amyloid precursor proteins for identifying candidate therapeutics |
| 08/27/2002 | US6440697 Ring finger protein zapop3 |
| 08/27/2002 | US6440696 E6 targeted protein (E6TP1) |
| 08/27/2002 | US6440694 Which is a tumor necrosis factor (tnf) homolog of given nucleotide sequence and amino acid sequence |
| 08/27/2002 | US6440693 Given amino acid sequence; recombinant tumor necrosis factor (tnf)-binding protein useful in pharmaceuticals for inhibiting tnf |
| 08/27/2002 | US6440690 Peptides for the activation of the immune system in humans and animals |
| 08/27/2002 | US6440680 Using dna encoding the novel prostaglandin receptor and host cells expressing the receptor |
| 08/27/2002 | US6440679 Dermatomyositis-specific auto-antigen |
| 08/27/2002 | US6440674 Plant promoter derived from luminal binding protein gene and methods for its use |
| 08/27/2002 | US6440672 Compositions and methods for the inhibition of MUC-5 mucin gene expression |
| 08/27/2002 | US6440670 Allele of human histamine H2 receptor and methods of detection of H2 receptor variants |
| 08/27/2002 | US6440666 Detecting alleles of a gene responsible for autosomal dwarfism in chickens by hybridizing nucleic acid probe(s) derived from a recombinant nucleic acid associated with autosomal dwarfism in chicken |
| 08/27/2002 | US6440665 Modified bioluminescent proteins and their use |
| 08/27/2002 | US6440663 Renal cancer associated antigens and uses therefor |
| 08/27/2002 | US6440656 Methods for the inhibition of respiratory syncytial virus transmission |
| 08/27/2002 | US6440425 High molecular weight major outer membrane protein of moraxella |
| 08/27/2002 | US6440424 High molecular weight major outer membrane protein of moraxella |
| 08/27/2002 | US6440423 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 08/27/2002 | US6440422 Expressing foreign genes inserted at site of naturally occurring deletion in modified vaccinia virus ankara genome; polypeptides, e.g. antigens or therapeutic agents, or viral vectors for gene therapy; encoding antigens as vaccines |
| 08/27/2002 | US6440421 Treatment of bone disorders with adrenomedullin or adrenomedullin agonists |
| 08/27/2002 | US6440412 Purified forms of DNase |
| 08/27/2002 | US6440409 Method for efficient and highly selective control of microorganisms |
| 08/27/2002 | US6440407 Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides |
| 08/27/2002 | CA2231738C Stress resistant plant in which cell death suppressing gene is introduced and method for producing the same |
| 08/27/2002 | CA2173939C Oligopeptides derived from c-reactive protein fragments |
| 08/27/2002 | CA2069929C Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 08/27/2002 | CA2018592C Polypeptides and polypeptide analogues with inhibitory activity against human elastase |
| 08/23/2002 | WO2003102013A2 Methods and compositions for production of recombinant peptides |
| 08/23/2002 | CA2444480A1 Methods and compositions for production of recombinant peptides |
| 08/23/2002 | CA2370213A1 Assays for assessing a.beta.-tau aggregation |
| 08/22/2002 | WO2002065134A2 Modulators of p53-p300 interactions and screening methods therefor |
| 08/22/2002 | WO2002065129A2 Epitopic sequences for diagnosing infection by chlamydia trachomatis |
| 08/22/2002 | WO2002065089A2 Catabolite repression control (crc) gene and pseudomonas virulence |
| 08/22/2002 | WO2002064843A1 Ecteinascidin family compounds: compositions and methods |